Ergoline (BioDeep_00000178780)
human metabolite blood metabolite
代谢物信息卡片
6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraene
化学式: C14H16N2 (212.1313)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: C1CC2C(CC3=CNC4=CC=CC2=C34)NC1
InChI: InChI=1S/C14H16N2/c1-3-11-10-4-2-6-15-13(10)7-9-8-16-12(5-1)14(9)11/h1,3,5,8,10,13,15-16H,2,4,6-7H2
描述信息
同义名列表
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
| 亚细胞结构定位 | 关联基因列表 |
|---|
文献列表
- Isabelle Boucoiran, Melissa Roy, Vanessa Poliquin, Chelsea Elwood, Nancy L Sheehan, Rosie Thibaudeau, Ema Ferreira, Julie Autmizguine, Fatima Kakkar, Marc Boucher, Deborah Money, Karen Tulloch. Evaluation of cabergoline for lactation inhibition in women living with HIV.
International journal of STD & AIDS.
2021 06; 32(7):654-661. doi:
10.1177/0956462420984694. [PMID: 33612017] - Lukas Andereggen, Janine Frey, Emanuel Christ. Long-term IGF-1 monitoring in prolactinoma patients treated with cabergoline might not be indicated.
Endocrine.
2021 04; 72(1):216-222. doi:
10.1007/s12020-020-02557-1. [PMID: 33275185] - Wiebke Rudolph, Daniela Remane, Dirk K Wissenbach, Frank T Peters. Comparative study on the metabolism of the ergot alkaloids ergocristine, ergocryptine, ergotamine, and ergovaline in equine and human S9 fractions and equine liver preparations.
Xenobiotica; the fate of foreign compounds in biological systems.
2019 Oct; 49(10):1149-1157. doi:
10.1080/00498254.2018.1542187. [PMID: 30623698] - Chitra Choudhary, Amir H Hamrahian, James F Bena, Pablo Recinos, Laurence Kennedy, Georgiana Dobri. THE EFFECT OF RALOXIFENE ON SERUM PROLACTIN LEVEL IN PATIENTS WITH PROLACTINOMA.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
2019 Jul; 25(7):684-688. doi:
10.4158/ep-2018-0321. [PMID: 30865525] - Mehrnaz Imani, Mohammad Ebrahim Khamseh, Poopak Asadi, Mohammad Ghorbani, Hamideh Akbari, Fariba Alaei-Shahmiri, Maryam Honardoost, Mahmoud Reza Kaynama, Mojtaba Malek. COMPARISON OF CABERGOLINE VERSUS RALOXIFENE ADD-ON THERAPY TO LONG-ACTING SOMATOSTATIN ANALOGUE IN PATIENTS WITH INADEQUATELY CONTROLLED ACROMEGALY: A RANDOMIZED OPEN LABEL CLINICAL TRIAL.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
2018 Jun; 24(6):542-547. doi:
10.4158/ep-2017-0195. [PMID: 29949429] - Cristina Cosio, Elena Sartori, Marcello Garatti, Lorenzo Luccardini, G C M Grinwis, Hans S Kooistra, Federico Fracassi. Prolactinoma in a Dog.
Veterinary pathology.
2017 11; 54(6):972-976. doi:
10.1177/0300985817726118. [PMID: 28812531] - Ricardo Costa, C A Santa-Maria, D M Scholtens, S Jain, L Flaum, W J Gradishar, C V Clevenger, V G Kaklamani. A pilot study of cabergoline for the treatment of metastatic breast cancer.
Breast cancer research and treatment.
2017 Oct; 165(3):585-592. doi:
10.1007/s10549-017-4370-x. [PMID: 28674764] - Shalini Kunasegaran, Michael S Croxson, Ian Holdaway, Rinki Murphy. An unusual case of Cushing's syndrome due to bihormonal ACTH-prolactin secreting pituitary macroadenoma with rapid response to cabergoline.
BMJ case reports.
2017 Aug; 2017(?):. doi:
10.1136/bcr-2017-219921. [PMID: 28784879] - Margarida Teixeira, Pedro Souteiro, Davide Carvalho. Prolactinoma management: predictors of remission and recurrence after dopamine agonists withdrawal.
Pituitary.
2017 Aug; 20(4):464-470. doi:
10.1007/s11102-017-0806-x. [PMID: 28523537] - F Hasanpour, M Taei, S H Banitaba, M Heidari. Template synthesis of maghemite nanoparticle in carboxymethyl cellulose and its application for electrochemical cabergoline sensing.
Materials science & engineering. C, Materials for biological applications.
2017 Jul; 76(?):88-93. doi:
10.1016/j.msec.2017.02.128. [PMID: 28482603] - Robert Krysiak, Witold Szkróbka, Bogusław Okopień. Alternative Treatment Strategies in Women Poorly Tolerating Moderate Doses of Bromocriptine.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
2017 Jun; 125(6):360-364. doi:
10.1055/s-0042-123041. [PMID: 28073129] - A Ferriere, C Cortet, P Chanson, B Delemer, P Caron, O Chabre, Y Reznik, J Bertherat, V Rohmer, C Briet, I Raingeard, F Castinetti, A Beckers, L Vroonen, D Maiter, F L Cephise-Velayoudom, M L Nunes, M Haissaguerre, A Tabarin. Cabergoline for Cushing's disease: a large retrospective multicenter study.
European journal of endocrinology.
2017 Mar; 176(3):305-314. doi:
10.1530/eje-16-0662. [PMID: 28007845] - Asghar Mogheiseh, Mohammad Javad Mosavi Ghiri, Esmaeil Bandarian. The Clinical Follow-Up of Estradiol Benzoate Priming During Induction of Estrus With Cabergoline in Dogs.
Topics in companion animal medicine.
2017 Mar; 32(1):16-19. doi:
10.1053/j.tcam.2017.07.001. [PMID: 28750784] - Shinya Watanabe, Hiroyoshi Akutsu, Shingo Takano, Tetsuya Yamamoto, Eiichi Ishikawa, Hiroaki Suzuki, Akira Matsumura. Long-term results of cabergoline therapy for macroprolactinomas and analyses of factors associated with remission after withdrawal.
Clinical endocrinology.
2017 Feb; 86(2):207-213. doi:
10.1111/cen.13240. [PMID: 27651307] - Selma Mourad, Julie Brown, Cindy Farquhar. Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews.
The Cochrane database of systematic reviews.
2017 01; 1(?):CD012103. doi:
10.1002/14651858.cd012103.pub2. [PMID: 28111738] - Pedro Iglesias, Carles Villabona, Juan José Díez. [Serum concentrations of glucose, cholesterol and triglycerides in men with prolactinoma treated with cabergoline].
Medicina clinica.
2016 Nov; 147(10):466-467. doi:
10.1016/j.medcli.2016.05.025. [PMID: 27452305] - Ilyas M Eli, Amol Raheja, Heather J Corn, Debra L Simmons, Cheryl Ann Palmer, William T Couldwell. Sellar Wegener Granulomatosis Masquerading as Cabergoline-Resistant Prolactinoma.
World neurosurgery.
2016 Nov; 95(?):622.e1-622.e5. doi:
10.1016/j.wneu.2016.07.108. [PMID: 27521731] - M Boutinaud, N Isaka, V Lollivier, F Dessauge, E Gandemer, P Lamberton, A I De Prado Taranilla, A Deflandre, L M Sordillo. Cabergoline inhibits prolactin secretion and accelerates involution in dairy cows after dry-off.
Journal of dairy science.
2016 Jul; 99(7):5707-5718. doi:
10.3168/jds.2015-10782. [PMID: 27179868] - Nur Şahin, Nesin Apaydın, Emrah Töz, Oya Nermin Sivrikoz, Mine Genç, Gülüzar Arzu Turan, Hakan Cengiz, Fatma Eskicioğlu. Comparison of the effects of letrozole and cabergoline on vascular permeability, ovarian diameter, ovarian tissue VEGF levels, and blood PEDF levels, in a rat model of ovarian hyperstimulation syndrome.
Archives of gynecology and obstetrics.
2016 May; 293(5):1101-6. doi:
10.1007/s00404-015-3987-4. [PMID: 26690356] - Pia Burman, Britt Edén-Engström, Bertil Ekman, F Anders Karlsson, Erik Schwarcz, Jeanette Wahlberg. Limited value of cabergoline in Cushing's disease: a prospective study of a 6-week treatment in 20 patients.
European journal of endocrinology.
2016 Jan; 174(1):17-24. doi:
10.1530/eje-15-0807. [PMID: 26582653] - Iván E Laboy-Ortiz, Sharon Velez-Maymí, José Hernán Martínez, Rafael Trinidad, Michelle Mangual, Alfredo Sanchez, Madeline Gutierrez, Paola Mansilla, Carmen Rivera, Coromoto Palermo, María de Lourdes Miranda, Ricardo Brau. Secondary Resistance to dopamine agonist after thirteen months of successful treatment in a 42 years old man.
Boletin de la Asociacion Medica de Puerto Rico.
2016; 108(1):31-36. doi:
NULL. [PMID: 29193928] - Annelien De Pue, Bart Lutin, Koen Paemeleire. Chronic cluster headache and the pituitary gland.
The journal of headache and pain.
2016; 17(?):23. doi:
10.1186/s10194-016-0614-0. [PMID: 26969187] - Eider Pascual-Corrales, Alejandra Tomás Velázquez, José Luis Zubieta, Javier Salvador, Juan Carlos Galofré. Cabergoline for Cushing's disease: A case report.
Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion.
2015 Dec; 62(10):516-8. doi:
10.1016/j.endonu.2015.07.002. [PMID: 26307390] - Vera Fernandes, Maria Joana Santos, Rui Almeida, Olinda Marques. Ten-year follow-up of a giant prolactinoma.
BMJ case reports.
2015 Nov; 2015(?):. doi:
10.1136/bcr-2015-212221. [PMID: 26590188] - Muzaffer Ilhan, Ozlem Timirci Kahraman, Saime Turan, Seda Turgut, Ozcan Karaman, Umit Zeybek, Samir Shukurov, Ilhan Yaylim, Ertugrul Tasan. Does DRD2 polymorphism influence the clinical characteristics of prolactinoma?.
Annales d'endocrinologie.
2015 Oct; 76(5):614-9. doi:
10.1016/j.ando.2015.08.005. [PMID: 26514951] - R Krysiak, J Okrzesik, B Okopien. Different Effects of Metformin on the Hypothalamic-Pituitary-Thyroid Axis in Bromocriptine- and Cabergoline-treated Patients with Hashimoto's Thyroiditis and Glucose Metabolism Abnormalities.
Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.
2015 Oct; 123(9):561-6. doi:
10.1055/s-0035-1564073. [PMID: 26372847] - A Bach, A De-Prado, A Aris. Short communication: The effects of cabergoline administration at dry-off of lactating cows on udder engorgement, milk leakages, and lying behavior.
Journal of dairy science.
2015 Oct; 98(10):7097-101. doi:
10.3168/jds.2015-9751. [PMID: 26277312] - F S Cunha, S Domenice, V L Câmara, M H P Sircili, L J G Gooren, B B Mendonça, E M F Costa. Diagnosis of prolactinoma in two male-to-female transsexual subjects following high-dose cross-sex hormone therapy.
Andrologia.
2015 Aug; 47(6):680-4. doi:
10.1111/and.12317. [PMID: 25059808] - Mussa H Almalki, Badurudeen Buhary, Saad Alzahrani, Fahad Alshahrani, Safia Alsherbeni, Ghada Alhowsawi, Naji Aljohani. Giant prolactinomas: clinical manifestations and outcomes of 16 Arab cases.
Pituitary.
2015 Jun; 18(3):405-9. doi:
10.1007/s11102-014-0588-3. [PMID: 25062894] - A Arduc, F Gokay, S Isik, U Ozuguz, G Akbaba, Y Tutuncu, D Berker, F K Kucukler, Y Aydin, S Guler. Retrospective comparison of cabergoline and bromocriptine effects in hyperprolactinemia: a single center experience.
Journal of endocrinological investigation.
2015 Apr; 38(4):447-53. doi:
10.1007/s40618-014-0212-4. [PMID: 25421155] - Robert Krysiak, Bogusław Okopien. Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels.
Basic & clinical pharmacology & toxicology.
2015 Mar; 116(3):251-6. doi:
10.1111/bcpt.12307. [PMID: 25123447] - Hadar Amir, Dan Yaniv, Joseph Hasson, Ami Amit, David Gordon, Foad Azem. Cabergoline for reducing ovarian hyperstimulation syndrome in assisted reproductive technology treatment cycles. A prospective randomized controlled trial.
The Journal of reproductive medicine.
2015 Jan; 60(1-2):48-54. doi:
NULL. [PMID: 25745751] - Elzbieta Andrysiak-Mamos, Agnieszka Kaźmierczyk-Puchalska, Ewa Zochowska, Elzbieta Sowińska-Przepiera, Leszek Sagan, Ireneusz Kojder, Anhelli Syrenicz. Evaluaton of therapy with cabergoline in men with macroprolactinoa.
Pomeranian journal of life sciences.
2015; 61(3):263-9. doi:
NULL. [PMID: 27344867] - M Lombardi, I Lupi, M Cosottini, G Rossi, L Manetti, V Raffaelli, C Sardella, E Martino, F Bogazzi. Lower prolactin levels during cabergoline treatment are associated to tumor shrinkage in prolactin secreting pituitary adenoma.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
2014 Dec; 46(13):939-42. doi:
10.1055/s-0034-1389925. [PMID: 25230324] - Ratchaneewan Kwancharoen, Renata Simona Auriemma, Gayane Yenokyan, Gary S Wand, Annamaria Colao, Roberto Salvatori. Second attempt to withdraw cabergoline in prolactinomas: a pilot study.
Pituitary.
2014 Oct; 17(5):451-6. doi:
10.1007/s11102-013-0525-x. [PMID: 24078319] - Kari A Morfeld, Ray L Ball, Janine L Brown. Recurrence of hyperprolactinemia and continuation of ovarian acyclicity in captive African elephants (Loxodonta africana) treated with cabergoline.
Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians.
2014 Sep; 45(3):569-76. doi:
10.1638/2013-0254r.1. [PMID: 25314824] - Yves P Auberson, Thomas Troxler, Xuechun Zhang, Charles R Yang, Markus Fendt, Dominik Feuerbach, Yu-Chih Liu, Bharat Lagu, Andreas Lerchner, Mark Perrone, Lijun Lei, Chao Zhang, Chunxiu Wang, Tie-Lin Wang, Mark G Bock. Ergoline-derived inverse agonists of the human h3 receptor for the treatment of narcolepsy.
ChemMedChem.
2014 Aug; 9(8):1683-96. doi:
10.1002/cmdc.201402055. [PMID: 24850792] - Sarwar Malik, Syed Zubair Hussain, Rabia Basit, Najia Idress, Aysha Habib, Muhammad Zamant, Najmul Islam. Demographic characteristics, presentations and treatment outcome of patients with prolactinoma.
Journal of Ayub Medical College, Abbottabad : JAMC.
2014 Jul; 26(3):269-74. doi:
NULL. [PMID: 25671924] - R van der Pas, J H M van Esch, C de Bruin, A H J Danser, A M Pereira, P M Zelissen, R Netea-Maier, D M Sprij-Mooij, I M van den Berg-Garrelds, R H N van Schaik, S W J Lamberts, A H van den Meiracker, L J Hofland, R A Feelders. Cushing's disease and hypertension: in vivo and in vitro study of the role of the renin-angiotensin-aldosterone system and effects of medical therapy.
European journal of endocrinology.
2014 Feb; 170(2):181-91. doi:
10.1530/eje-13-0477. [PMID: 24165019] - Marina Boscolo, Danielle Baleriaux, Nathalie Bakoto, Bernard Corvilain, France Devuyst. Acute aseptic meningitis as the initial presentation of a macroprolactinoma.
BMC research notes.
2014 Jan; 7(?):9. doi:
10.1186/1756-0500-7-9. [PMID: 24398140] - R van der Pas, C de Bruin, A M Pereira, J A Romijn, R T Netea-Maier, A R Hermus, P M Zelissen, F H de Jong, A J van der Lely, W W de Herder, S M Webb, S W J Lamberts, L J Hofland, R A Feelders. Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing's disease.
Pituitary.
2013 Dec; 16(4):536-44. doi:
10.1007/s11102-012-0452-2. [PMID: 23225121] - Aline B Moraes, Cintia Marques dos Santos Silva, Leonardo Vieira Neto, Mônica R Gadelha. Giant prolactinomas: the therapeutic approach.
Clinical endocrinology.
2013 Oct; 79(4):447-56. doi:
10.1111/cen.12242. [PMID: 23662975] - Roberto Matorras, Maider Andrés, Rosario Mendoza, Begoña Prieto, Jose Ignacio Pijoan, Antonia Expósito. Prevention of ovarian hyperstimulation syndrome in GnRH agonist IVF cycles in moderate risk patients: randomized study comparing hydroxyethyl starch versus cabergoline and hydroxyethyl starch.
European journal of obstetrics, gynecology, and reproductive biology.
2013 Oct; 170(2):439-43. doi:
10.1016/j.ejogrb.2013.07.010. [PMID: 23932181] - Hidetoshi Ikeda, Kazuo Watanabe, Teiji Tominaga, Takashi Yoshimoto. Transsphenoidal microsurgical results of female patients with prolactinomas.
Clinical neurology and neurosurgery.
2013 Sep; 115(9):1621-5. doi:
10.1016/j.clineuro.2013.02.016. [PMID: 23498159] - Lynnette K Nieman. Update in the medical therapy of Cushing's disease.
Current opinion in endocrinology, diabetes, and obesity.
2013 Aug; 20(4):330-4. doi:
10.1097/med.0b013e3283631809. [PMID: 23807605] - Juan J Díez, Pedro Iglesias. [Optimization of the medical treatment for acromegaly].
Medicina clinica.
2013 Apr; 140(8):360-5. doi:
10.1016/j.medcli.2012.07.024. [PMID: 23103101] - Kentaro Suda, Naoko Inoshita, Genzo Iguchi, Hidenori Fukuoka, Michiko Takahashi, Hitoshi Nishizawa, Masaaki Yamamoto, Shozo Yamada, Yutaka Takahashi. Efficacy of combined octreotide and cabergoline treatment in patients with acromegaly: a retrospective clinical study and review of the literature.
Endocrine journal.
2013; 60(4):507-15. doi:
. [PMID: 23291436] - Peter Cackett, Graeme Eunson, Louise Bath, Alan Mulvihill. Proptosis as the presenting sign of giant prolactinoma in a prepubertal boy: successful resolution of hydrocephalus by use of medical therapy.
Future oncology (London, England).
2012 Dec; 8(12):1621-6. doi:
10.2217/fon.12.149. [PMID: 23231524] - Shrikant Patil, Ranjeet Prasad Dash, Sheetal Anandjiwala, Manish Nivsarkar. Simultaneous quantification of berberine and lysergol by HPLC-UV: evidence that lysergol enhances the oral bioavailability of berberine in rats.
Biomedical chromatography : BMC.
2012 Oct; 26(10):1170-5. doi:
10.1002/bmc.2674. [PMID: 22213237] - Jana Phillips, Honey E East, Sarah E French, Eugen Melcescu, Robert D Hamilton, William C Nicholas, Jonathan F Fratkin, Andrew D Parent, Gustavo Luzardo, Christian A Koch. What causes a prolactinoma to be aggressive or to become a pituitary carcinoma?.
Hormones (Athens, Greece).
2012 Oct; 11(4):477-82. doi:
10.14310/horm.2002.1380. [PMID: 23422771] - Stefano de Biase, Giovanni Merlino, Simone Lorenzut, Mariarosaria Valente, Gian Luigi Gigli. ADMET considerations for restless leg syndrome drug treatments.
Expert opinion on drug metabolism & toxicology.
2012 Oct; 8(10):1247-61. doi:
10.1517/17425255.2012.708023. [PMID: 22808933] - Gennaro Bussone, Susanna Usai, Franca Moschiano. How to investigate and treat: headache and hyperprolactinemia.
Current pain and headache reports.
2012 Aug; 16(4):365-70. doi:
10.1007/s11916-012-0267-x. [PMID: 22639180] - Seyyed Morteza Taghavi, Seyyede Sedighe Fatemi, Hale Rokni. Cabergoline effect on blood sugar in type 2 diabetic patients with oral agent failure.
The Medical journal of Malaysia.
2012 Aug; 67(4):390-2. doi:
NULL. [PMID: 23082447] - Jan Anker Jahnsen, Staffan Uhlén. The N-terminal region of the human 5-HT₂C receptor has as a cleavable signal peptide.
European journal of pharmacology.
2012 Jun; 684(1-3):44-50. doi:
10.1016/j.ejphar.2012.03.043. [PMID: 22497996] - P C Johnston, H C Courtney, S J Hunter, D R Mc Cance. Macroprolactinomas presenting as nasal polyps: a series of three cases.
Irish journal of medical science.
2012 Jun; 181(2):277-9. doi:
10.1007/s11845-009-0313-9. [PMID: 19288176] - D Nak, Y Nak, G Simsek. Comparison of the use of cabergoline and gonadotrophin to treat primary and secondary anoestrus in bitches.
Australian veterinary journal.
2012 May; 90(5):194-6. doi:
10.1111/j.1751-0813.2012.00913.x. [PMID: 22510079] - Ramón Coronas, Jesús Cobo, Olga Giménez-Palop, Emilio Ortega, Manel Márquez. Safety of cabergoline in the management of pituitary prolactin-induced symptoms with patients treated with atypical neuroleptics.
Current drug safety.
2012 Apr; 7(2):92-8. doi:
10.2174/157488612802715753. [PMID: 22873493] - C D Gibson, W Karmally, D J McMahon, S L Wardlaw, J Korner. Randomized pilot study of cabergoline, a dopamine receptor agonist: effects on body weight and glucose tolerance in obese adults.
Diabetes, obesity & metabolism.
2012 Apr; 14(4):335-40. doi:
10.1111/j.1463-1326.2011.01534.x. [PMID: 22074059] - C E Higham, A B Atkinson, S Aylwin, M Bidlingmaier, W M Drake, A Lewis, N M Martin, V Moyes, J Newell-Price, P J Trainer. Effective combination treatment with cabergoline and low-dose pegvisomant in active acromegaly: a prospective clinical trial.
The Journal of clinical endocrinology and metabolism.
2012 Apr; 97(4):1187-93. doi:
10.1210/jc.2011-2603. [PMID: 22278424] - R van der Pas, C de Bruin, F W G Leebeek, M P M de Maat, D C Rijken, A M Pereira, J A Romijn, R T Netea-Maier, A R Hermus, P M J Zelissen, F H de Jong, A J van der Lely, W W de Herder, S W J Lamberts, L J Hofland, R A Feelders. The hypercoagulable state in Cushing's disease is associated with increased levels of procoagulant factors and impaired fibrinolysis, but is not reversible after short-term biochemical remission induced by medical therapy.
The Journal of clinical endocrinology and metabolism.
2012 Apr; 97(4):1303-10. doi:
10.1210/jc.2011-2753. [PMID: 22278425] - Ensieh Shahrokh Tehraninejad, Maryam Hafezi, Arezoo Arabipoor, Elham Aziminekoo, Mohammad Chehrazi, Akram Bahmanabadi. Comparison of cabergoline and intravenous albumin in the prevention of ovarian hyperstimulation syndrome: a randomized clinical trial.
Journal of assisted reproduction and genetics.
2012 Mar; 29(3):259-64. doi:
10.1007/s10815-011-9708-4. [PMID: 22231013] - Evdoxia Tsigkaropoulou, Melpomeni Peppa, Christina Zompola, Emmanouil Rizos, Ioanna Xelioti, Sofia Chatziioannou, Anastasia Filippopoulou, Lefteris Lykouras. Hypogonadism due to hyperprolactinemia and subsequent first episode of psychosis.
Gender medicine.
2012 Feb; 9(1):56-60. doi:
10.1016/j.genm.2012.01.001. [PMID: 22333523] - Shinya Watanabe, Shingo Takano, Hiroyoshi Akutsu, Hiroshige Sato, Akira Matsumura. [Prolactinoma treatment status in the cabergoline era].
No shinkei geka. Neurological surgery.
2011 Nov; 39(11):1045-54. doi:
NULL. [PMID: 22036815] - S R Gooneratne, M Scannell, M Wellby, L Fletcher. Changes in concentrations of lysergol in urine and prolactin in plasma, rectal temperature and respiration rate in sheep selected for resistance or susceptibility to ryegrass staggers and fed ergovaline.
New Zealand veterinary journal.
2011 Sep; 59(5):233-8. doi:
10.1080/00480169.2011.601538. [PMID: 21851300] - A R Agaoglu, S Schäfer-Somi, D Kaya, I Kucukaslan, B Emre, N Gultiken, B S Mulazımoglu, A Colak, S Aslan. The intravaginal application of misoprostol improves induction of abortion with aglepristone.
Theriogenology.
2011 Jul; 76(1):74-82. doi:
10.1016/j.theriogenology.2011.01.019. [PMID: 21458052] - Pallavi Iyer, Mark E Molitch. Positive prolactin response to bromocriptine in 2 patients with cabergoline-resistant prolactinomas.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
2011 May; 17(3):e55-8. doi:
10.4158/ep10369.cr. [PMID: 21324816] - B M Verdel, P C Souverein, S D Meenks, E R Heerdink, H G M Leufkens, T C G Egberts. Use of serotonergic drugs and the risk of bleeding.
Clinical pharmacology and therapeutics.
2011 Jan; 89(1):89-96. doi:
10.1038/clpt.2010.240. [PMID: 21107313] - Anurag R Lila, Raju A Gopal, Shrikrishna V Acharya, Joe George, Vijaya Sarathi, Tushar Bandgar, Padma S Menon, Nalini S Shah. Efficacy of cabergoline in uncured (persistent or recurrent) Cushing disease after pituitary surgical treatment with or without radiotherapy.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
2010 Nov; 16(6):968-76. doi:
10.4158/ep10031.or. [PMID: 20497937] - Esra Esim Buyukbayrak, Ayse Yasemin Karageyim Karsidag, Bulent Kars, Orhan Balcik, Meltem Pirimoglu, Orhan Unal, Cem Turan. Effectiveness of short-term maintenance treatment with cabergoline in microadenoma-related and idiopathic hyperprolactinemia.
Archives of gynecology and obstetrics.
2010 Nov; 282(5):561-6. doi:
10.1007/s00404-010-1562-6. [PMID: 20571820] - Ariane Godbout, Marcos Manavela, Karina Danilowicz, Hugues Beauregard, Oscar Domingo Bruno, André Lacroix. Cabergoline monotherapy in the long-term treatment of Cushing's disease.
European journal of endocrinology.
2010 Nov; 163(5):709-16. doi:
10.1530/eje-10-0382. [PMID: 20702648] - Amandine Bertrand, Perrine Marec-Berard, Gerald Raverot, Jacqueline Trouillas, Aurélien Marabelle. Cabergoline therapy of paraneoplastic Cushing syndrome in children.
Pediatric blood & cancer.
2010 Sep; 55(3):589-90. doi:
10.1002/pbc.22581. [PMID: 20658641] - Oscar D Bruno, Karina Danilowicz, Marcos Manavela, Daniela Mana, Maria A Rossi. Long-term management with octreotide or cabergoline in ectopic corticotropin hypersecretion: case report and literature review.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
2010 Sep; 16(5):829-34. doi:
10.4158/ep09286.cr. [PMID: 20497940] - Lucio Vilar, Luciana A Naves, Monalisa F Azevedo, Maria Juliana Arruda, Carla M Arahata, Lidiane Moura E Silva, Rodrigo Agra, Lisete Pontes, Larissa Montenegro, José Luciano Albuquerque, Viviane Canadas. Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease.
Pituitary.
2010 Jun; 13(2):123-9. doi:
10.1007/s11102-009-0209-8. [PMID: 19943118] - Richard A Feelders, Christiaan de Bruin, Alberto M Pereira, Johannes A Romijn, Romana T Netea-Maier, Ad R Hermus, Pierre M Zelissen, Ramona van Heerebeek, Frank H de Jong, Aart-Jan van der Lely, Wouter W de Herder, Leo J Hofland, Steven W Lamberts. Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease.
The New England journal of medicine.
2010 May; 362(19):1846-8. doi:
10.1056/nejmc1000094. [PMID: 20463350] - A Bhansali, R Walia, P Dutta, N Khandelwal, R Sialy, S Bhadada. Efficacy of cabergoline on rapid escalation of dose in men with macroprolactinomas.
The Indian journal of medical research.
2010 Apr; 131(?):530-5. doi:
NULL. [PMID: 20424304] - Shrikrishna V Acharya, Raju A Gopal, Padma S Menon, Tushar R Bandgar, Nalini S Shah. Giant prolactinoma and effectiveness of medical management.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
2010 Jan; 16(1):42-6. doi:
10.4158/ep09221.or. [PMID: 19703803] - G Ajitkumar, T Sreekumaran, R Praseeda, K A Mercy, K N Aravinda Ghosh. Comparative efficacy of bromocriptine, cabergoline and thyroxine in inducing oestrus in bitches.
Veterinary research communications.
2010 Jan; 34(1):65-9. doi:
10.1007/s11259-009-9333-1. [PMID: 20012189] - Eun-Hee Cho, Sang Ah Lee, Ji Youn Chung, Eun Hee Koh, Young Hyun Cho, Jeong Hoon Kim, Chang Jin Kim, Min-Seon Kim. Efficacy and safety of cabergoline as first line treatment for invasive giant prolactinoma.
Journal of Korean medical science.
2009 Oct; 24(5):874-8. doi:
10.3346/jkms.2009.24.5.874. [PMID: 19794986] - Sanjeev Bhattacharyya, Anthony H Schapira, Dimitri P Mikhailidis, Joseph Davar. Drug-induced fibrotic valvular heart disease.
Lancet (London, England).
2009 Aug; 374(9689):577-85. doi:
10.1016/s0140-6736(09)60252-x. [PMID: 19683643] - S Romagnoli, C Milani, S Perin, R Ballabio, C Stelletta, A Mollo, D Gelli. Effect of an injectable cabergoline formulation on serum prolactin (PRL) and milk secretion in early postpartum Beagle bitches.
Reproduction in domestic animals = Zuchthygiene.
2009 Jul; 44 Suppl 2(?):148-51. doi:
10.1111/j.1439-0531.2009.01440.x. [PMID: 19754555] - A R Günzel-Apel, T Höftmann, S Nottorf, E Politt, A Meyer-Lindenberg, H O Hoppen, A Einspanier, H M Knijn, R Mischke. Influence of progesterone withdrawal on pregnancy-related parameters during post-implantation early pregnancy loss.
Reproduction in domestic animals = Zuchthygiene.
2009 Jul; 44 Suppl 2(?):174-81. doi:
10.1111/j.1439-0531.2009.01381.x. [PMID: 19754562] - P G Blanco, D Arias, A Rube, J P Barrena, Y Corrada, C Gobello. An experimental model to study resistance index and systolic/diastolic ratio of uterine arteries in adverse canine pregnancy outcome.
Reproduction in domestic animals = Zuchthygiene.
2009 Jul; 44 Suppl 2(?):164-6. doi:
10.1111/j.1439-0531.2009.01369.x. [PMID: 19754559] - M B Koivisto, F Eschricht, C Urhausen, H O Hoppen, M Beyerbach, C H Y Oei, A R Günzel-Apel. Effects of short-term hyper- and hypoprolactinaemia on hormones of the pituitary, gonad and -thyroid axis and on semen quality in male Beagles.
Reproduction in domestic animals = Zuchthygiene.
2009 Jul; 44 Suppl 2(?):320-5. doi:
10.1111/j.1439-0531.2009.01425.x. [PMID: 19754595] - Hideki Ohno, Masashi Nakajima, Shinsuke Fujioka, Kohnosuke Iwamoto, Mitsuru Kawamura. Overnight switching from ergot-derived dopamine agonists to pramipexole in patients with Parkinson's disease: an open preliminary trial in Japan.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia.
2009 Jun; 16(6):790-2. doi:
10.1016/j.jocn.2008.09.001. [PMID: 19286385] - Bazoumana Ouattara, Samah Belkhir, Marc Morissette, Mehdi Dridi, Pershia Samadi, Laurent Grégoire, Leonard T Meltzer, Thérèse Di Paolo. Implication of NMDA receptors in the antidyskinetic activity of cabergoline, CI-1041, and Ro 61-8048 in MPTP monkeys with levodopa-induced dyskinesias.
Journal of molecular neuroscience : MN.
2009 Jun; 38(2):128-42. doi:
10.1007/s12031-008-9137-8. [PMID: 18704766] - Francisco Javier Velázquez-Chávez, María de Los Angeles Tapia-González, David González-Bárcena. [Usefulness of cabergoline in patients with prolactinemia and resistant or intolerant to bromocriptine].
Cirugia y cirujanos.
2009 May; 77(3):173-7. doi:
NULL. [PMID: 19671268] - A-R Günzel-Apel, A Seefeldt, F M Eschricht, C Urhausen, S Kramer, R Mischke, H-O Hoppen, M Beyerbach, M Koivisto, S J Dieleman. Effects of gonadectomy on prolactin and LH secretion and the pituitary-thyroid axis in male dogs.
Theriogenology.
2009 Mar; 71(5):746-53. doi:
10.1016/j.theriogenology.2008.09.047. [PMID: 18996577] - Rosario Pivonello, Maria Cristina De Martino, Paolo Cappabianca, Monica De Leo, Antongiulio Faggiano, Gaetano Lombardi, Leo J Hofland, Steven W J Lamberts, Annamaria Colao. The medical treatment of Cushing's disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery.
The Journal of clinical endocrinology and metabolism.
2009 Jan; 94(1):223-30. doi:
10.1210/jc.2008-1533. [PMID: 18957500] - Gitanjali Sharma, Anil Kumar Mishra, Pushpa Mishra, Ambikanandan Misra. Intranasal cabergoline: pharmacokinetic and pharmacodynamic studies.
AAPS PharmSciTech.
2009; 10(4):1321-30. doi:
10.1208/s12249-009-9329-8. [PMID: 19894122] - Shrikrishna V Acharya, Raju A Gopal, Tushar R Bandgar, Shashank R Joshi, Padma S Menon, Nalini S Shah. Clinical profile and long term follow up of children and adolescents with prolactinomas.
Pituitary.
2009; 12(3):186-9. doi:
10.1007/s11102-008-0149-8. [PMID: 18946737] - E Burri, R Nüesch, H Zulewski. [Hyperprolactinemia in a man's world].
Praxis.
2008 Dec; 97(24):1295-9. doi:
10.1024/1661-8157.97.24.1295. [PMID: 19048508] - Masami Ono, Nobuhiro Miki, Takakazu Kawamata, Rena Makino, Kosaku Amano, Toshiro Seki, Osami Kubo, Tomokatsu Hori, Kazue Takano. Prospective study of high-dose cabergoline treatment of prolactinomas in 150 patients.
The Journal of clinical endocrinology and metabolism.
2008 Dec; 93(12):4721-7. doi:
10.1210/jc.2007-2758. [PMID: 18812485] - Celia Larramendy, Irene R E Taravini, Mariano D Saborido, Juan E Ferrario, Mario G Murer, Oscar S Gershanik. Cabergoline and pramipexole fail to modify already established dyskinesias in an animal model of parkinsonism.
Behavioural brain research.
2008 Dec; 194(1):44-51. doi:
10.1016/j.bbr.2008.06.021. [PMID: 18638507] - V J Moyes, K A Metcalfe, W M Drake. Clinical use of cabergoline as primary and adjunctive treatment for acromegaly.
European journal of endocrinology.
2008 Nov; 159(5):541-5. doi:
10.1530/eje-08-0306. [PMID: 18708434] - Toshihiro Tajima, Junko Tsubaki, Katsura Ishizu, Wakako Jo, Nobuaki Ishi, Kenji Fujieda. Case study of a 15-year-old boy with McCune-Albright syndrome combined with pituitary gigantism: effect of octreotide-long acting release (LAR) and cabergoline therapy.
Endocrine journal.
2008 Jul; 55(3):595-9. doi:
10.1507/endocrj.k07e-042. [PMID: 18445999] - Manuel Heras, Pedro Iglesias, María J Fernández-Reyes, Rosa Sánchez, María J Jiménez, Henar Muñoz, Pilar Tajada, Jacinto Duarte. Nephrotic-range proteinuria in a patient with a giant prolactinoma.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2008 Jun; 51(6):1025-8. doi:
10.1053/j.ajkd.2008.02.310. [PMID: 18455849] - F Mouton, F Faivre-Defrance, C Cortet-Rudelli, R Assaker, G Soto-Ares, S Defoort-Dhellemmes, S Blond, J-L Wemeau, M-C Vantyghem. TSH-secreting adenoma improved with cabergoline.
Annales d'endocrinologie.
2008 Jun; 69(3):244-8. doi:
10.1016/j.ando.2008.02.001. [PMID: 18486933] - Johan A Verhelst, Pascale J Abrams, Roger Abs. Remission of acromegaly following long-term therapy with cabergoline: report of two cases.
Pituitary.
2008; 11(1):103-7. doi:
10.1007/s11102-007-0041-y. [PMID: 17530416] - Yasuhiro Kawabata, Yasushi Ueno, Fumihiko Horikawa, Hidenori Miyake, Nobuhiro Miki, Masami Ono. Remarkable effects of cabergoline in a patient with huge prolactinoma resistant to high-dose bromocriptine: case report.
Surgical neurology.
2008 Jan; 69(1):85-8; discussion 88. doi:
10.1016/j.surneu.2006.11.060. [PMID: 17967478]
